IMU 2.22% 4.6¢ imugene limited

"Do any of the posters who analyse our trials want to take a...

  1. 237 Posts.
    lightbulb Created with Sketch. 1106
    "Do any of the posters who analyse our trials want to take a stab at when we might see early results from OASIS?"

    Hi TB, although not yet confirmed, I believe the 27th Meeting of ASGCT (American Society of Gene and Cell Therapy) to be held on the 7th May in Baltimore Maryland will be the conference where we see early results from the OASIS trial.
    https://annualmeeting.asgct.org/
    The deadline for regular abstract submissions was the 26th January.
    Notifications will be sent on the 25th March and abstracts will be released on the 8th April.

    The results will most likely only be for the first two run in cohorts which do not include the Blincyto combination.

    I recall the response from Saul Priceman, when asked how long it will take to see efficacy results from OnCARlytics in combination.
    "It won't take long at all." It will be these results that will either confirm or deny the grounding breaking science of CF33-CD19.
    Subject to when the combination cohorts commence, these results may be announced at the ASCO (American Society of Oncology) 2024 Annual General Meeting in Chicago on the 31st May 2024.
    https://conferences.asco.org/am/attend
    Notifications will be sent on the 29th March and abstract titles will be published on the 24th April.


    GLTAH - Go Team Imugene
    .
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
0.001(2.22%)
Mkt cap ! $342.1M
Open High Low Value Volume
4.5¢ 4.7¢ 4.5¢ $906.2K 19.67M

Buyers (Bids)

No. Vol. Price($)
20 9543864 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 1266571 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.